Board of Pharmacy public meetings in 2023
4 substantive meetings from 2023, with official agendas or minutes and plain-English summaries.
Board of Pharmacy
The Board will conduct its annual election of officers and consider budget amendments for fiscal year 23-24. The meeting also includes reviews of pharmacy violations, application requests, and proposed policy changes regarding electronic meetings.
- Annual Election of Officers
- Proposed Budget Amendment No. 1 for Fiscal Year 23-24
- Proposed Budget for FY 24-25
- Consideration of Proposed Voluntary Consent Agreements involving multiple pharmacies and individuals
- Proposed Agreement for Hosting Services with Tyler Technologies
The Board approved the proposed budget for Fiscal Year 2024-2025 and a budget amendment for FY 2023-2024. It issued several fines and license restrictions to pharmacies and practitioners for regulatory violations. The Board also re-elected its current officers by acclamation.
- Re-elected current officers (President, three Vice Presidents, and Secretary) by acclamation
- Approved Proposed Budget Amendment No. 1 for FY 2023-2024 and Proposed Budget for FY 2024-2025
- Fined Express Pharmacy Solutions $25,000 for ownership transfer without proper application
- Fined three CVS Pharmacy locations (Alexandria, Marksville, Lafayette) $10,000, $10,000, and $30,000 respectively for PIC designation failures
- Revoked credential of Anita Renae Williams for failure to undergo directed evaluation
- Approved $160,000 agreement with Tyler Technologies for eLicense hosting and maintenance
- Granted Crescent City Therapeutics, LLC an extension until February 15, 2024, to commence marijuana pharmacy operations
- Approved a mileage restriction waiver for Express Rx of Saint Joseph to convert to a telepharmacy dispensing site
Board of Pharmacy
The Louisiana Board of Pharmacy will meet to consider several regulatory proposals, including temporary pharmacy closure, product integrity, automated medication systems, and prescription monitoring program changes. The board will also vote on numerous voluntary consent agreements involving pharmacies and pharmacists for alleged violations. Other business includes financial statements, new pharmacy applications, and a quarterly PMP report.
- Consideration of regulatory proposals 2023-B (product integrity), 2023-C (automated medication system), 2023-D (prescription monitoring program), and 2023-E (pharmacist application)
- Voluntary consent agreements for multiple CVS Pharmacy, Walgreens Pharmacy, and other locations (e.g., CVS #5544, Walgreens #4566, BAART Programs Alexandria)
- Consideration of compiled financial statements for fiscal year 2022-2023
- Presentation of Pharmacist Gold Certificates to Joel Seth Aronson and Severan Joseph Medine
- Consideration of new pharmacy application for Align Pharmacy, LLC
The Board approved several regulatory updates, including new rules for temporary pharmacy closures and product integrity. The Board also authorized the sale of its property at 6959 Commerce Circle in Baton Rouge and issued multiple disciplinary fines and license suspensions.
- Approved Regulatory Project 2023-02 regarding Temporary Closure of Pharmacy (unanimous)
- Approved Regulatory Proposal 2023-B regarding Product Integrity (unanimous)
- Approved Regulatory Proposal 2023-C regarding Automated Medication Systems (unanimous)
- Approved Regulatory Proposal 2023-D regarding Prescription Monitoring Program (unanimous)
- Approved Regulatory Proposal 2023-E regarding Pharmacists Application (unanimous)
- Authorized sale of property at 6959 Commerce Circle in Baton Rouge (unanimous)
- Approved FY 2022-2023 Compiled Financial Statements (unanimous)
- Approved 18 full and one partial PMP reporting waivers (unanimous)
Board of Pharmacy
The Louisiana Board of Pharmacy will meet to consider proposed regulatory changes regarding prescriptions, temporary pharmacy closures, and pharmacy benefit managers, following public hearings. The board will also review multiple proposed voluntary consent agreements in disciplinary cases and vote on annual contract renewals for legal, accounting, and IT services.
- Consideration of comments on Regulatory Project 2023-01 (Prescriptions)
- Consideration of comments on Regulatory Project 2023-03 (Pharmacy Benefit Managers)
- Proposed voluntary consent agreements for 9 cases including Neumann's Pharmacy and SU Student Health Services Pharmacy
- Annual renewal of contracts: legal services (Cangelosi, Shows Cali & Walsh), accounting (Champagne & Company), PMP (Appriss), IT (eLicense/Tyler Technologies)
- Consideration of proposed revisions to Policy & Procedure Manual (governance, attendance, pay, purchases)
The Board approved several professional service contracts for FY 2023-2024 and renewed operational manuals. It also issued disciplinary actions against multiple pharmacists and technicians and granted PMP reporting waivers to 23 pharmacies.
- Approved professional legal services contracts for Celia R. Cangelosi (up to $100,000) and Shows, Cali & Walsh (up to $50,000)
- Approved $800,000 agreement for PMP Gateway and NarxCare integration contingent on grant funds
- Approved $150,000 agreement for state prescription monitoring program vendor
- Revoked credential of Stacy Duwon Landrum Hull Nolan for theft of oxycodone tablets
- Approved voluntary consent agreements for 9 pharmacy-related disciplinary cases
- Granted reinstatement of lapsed certificates to 5 pharmacy technicians with specific requirements
- Authorized full PMP reporting waivers for 23 pharmacies
- Recognized that La. R.S. 40:978.2 supersedes Board regulations regarding Naloxone dispensing
Board of Pharmacy
The Louisiana Board of Pharmacy will consider proposed voluntary consent agreements for multiple pharmacies and pharmacists, including CVS, Walgreens, and Ochsner, for alleged violations. The board will also discuss regulatory proposals on staffing ratios, marijuana pharmacy, and immunization rules, as well as a contract modification with Bamboo Health Inc.
- Consideration of proposed voluntary consent agreements for 16 cases, including CVS Pharmacy #5331, #4068, #5607, Walgreen #02012, and Ochsner Foundation Hospital Pharmacy
- Consideration of regulatory proposals: staffing ratios (Draft #3), marijuana pharmacy (Draft #3), and DATA-waiver registration elimination (Draft #1)
- Consideration of legislative proposals: CDS schedule update (Draft #1) and immunizations (Draft #1)
- Consideration of contract modification with Bamboo Health Inc
- Consideration of requests for waivers from Prescription Monitoring Program (PMP) reporting
The Board approved several regulatory changes, including flexible staffing ratios for interns and technicians and updated pharmacy change of ownership procedures. It also ratified multiple disciplinary consent agreements involving fines and license revocations. Additionally, the Board approved a contract modification with Bamboo Health, Inc. for PMP integration services.
- Approved Regulatory Proposal 2022-M to allow flexible staffing ratios (unanimous)
- Approved Regulatory Proposal 2022-K regarding pharmacy change of ownership procedures (unanimous)
- Approved Regulatory Proposal 2022-O to reduce marijuana pharmacy regulations (unanimous)
- Approved revised agreement with Bamboo Health, Inc. not to exceed $800,000 (unanimous)
- Approved Legislative Proposal 2023-B to reduce PMP Advisory Council meetings (unanimous)
- Approved Legislative Proposal 2023-A to update CDS Schedule (unanimous)
- Approved $25,000 fine for CVS Pharmacy No. 4068 in Haughton (unanimous)
- Revoked credentials of Tony Roussell, Jr., Eugenia Marie Brignac Kocke, and Harlee Ellyssa Ellerbe Pierce (unanimous)